COLGAN ERIN (SVP of Finance) reported 1 transaction at FAETH THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/16/2024ACC: 0001415889-24-004234
Officer· SVP of Finance
Since Feb 2021
+215.50K
Net shares
Net buyer
$2.9K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
219.13K acquired · 3.63K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.63K
Price / share
$0.79
Trade value
$2.87K
% of position
5.1%
2/15/2024
71.09K→67.46K
Total
Net shares
−3.63K
Net value
-$2.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2024 | F · Tax Withholding | −3.63K | $0.79 | $2.87K | 5.1% | 71.09K | 67.46K |
| Total | −3.63K | -$2.87K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
125K shares
Shares
+125K
Strike price
0.79
Held after
125K
Exercisable
—
2/15/2024
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
94.13K shares
Shares
+94.13K
Strike price
0.79
Held after
94.13K
Exercisable
—
2/15/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock125K shares | 2/15/2024 | A · Award | +125K | 0.79 | — | 125K |
| Stock Option (Right to Buy) Direct | Common Stock94.13K shares | 2/15/2024 | A · Award | +94.13K | 0.79 | — | 94.13K |